These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 15106187

  • 1. Nonabsorbable disaccharides for hepatic encephalopathy.
    Als-Nielsen B, Gluud LL, Gluud C.
    Cochrane Database Syst Rev; 2004; (2):CD003044. PubMed ID: 15106187
    [Abstract] [Full Text] [Related]

  • 2. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Gluud LL, Vilstrup H, Morgan MY.
    Cochrane Database Syst Rev; 2016 Apr 18; 4():CD003044. PubMed ID: 27089005
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL, Dam G, Les I, Córdoba J, Marchesini G, Borre M, Aagaard NK, Vilstrup H.
    Cochrane Database Syst Rev; 2015 Feb 25; (2):CD001939. PubMed ID: 25715177
    [Abstract] [Full Text] [Related]

  • 7. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL, Dam G, Les I, Córdoba J, Marchesini G, Borre M, Aagaard NK, Vilstrup H.
    Cochrane Database Syst Rev; 2015 Sep 17; (9):CD001939. PubMed ID: 26377410
    [Abstract] [Full Text] [Related]

  • 8. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.
    Goh ET, Stokes CS, Sidhu SS, Vilstrup H, Gluud LL, Morgan MY.
    Cochrane Database Syst Rev; 2018 May 15; 5(5):CD012410. PubMed ID: 29762873
    [Abstract] [Full Text] [Related]

  • 9. Branched-chain amino acids for people with hepatic encephalopathy.
    Gluud LL, Dam G, Les I, Marchesini G, Borre M, Aagaard NK, Vilstrup H.
    Cochrane Database Syst Rev; 2017 May 18; 5(5):CD001939. PubMed ID: 28518283
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.
    Morgan MY.
    Metab Brain Dis; 2016 Dec 18; 31(6):1361-1364. PubMed ID: 27638474
    [Abstract] [Full Text] [Related]

  • 12. Probiotics for people with hepatic encephalopathy.
    Dalal R, McGee RG, Riordan SM, Webster AC.
    Cochrane Database Syst Rev; 2017 Feb 23; 2(2):CD008716. PubMed ID: 28230908
    [Abstract] [Full Text] [Related]

  • 13. Disaccharides in the treatment of hepatic encephalopathy.
    Sharma P, Sharma BC.
    Metab Brain Dis; 2013 Jun 23; 28(2):313-20. PubMed ID: 23456517
    [Abstract] [Full Text] [Related]

  • 14. Branched-chain amino acids for hepatic encephalopathy.
    Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C.
    Cochrane Database Syst Rev; 2003 Jun 23; (2):CD001939. PubMed ID: 12804416
    [Abstract] [Full Text] [Related]

  • 15. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial.
    Morgan MY, Hawley KE.
    Hepatology; 1987 Jun 23; 7(6):1278-84. PubMed ID: 3315932
    [Abstract] [Full Text] [Related]

  • 16. Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.
    Cammà C, Fiorello F, Tinè F, Marchesini G, Fabbri A, Pagliaro L.
    Dig Dis Sci; 1993 May 23; 38(5):916-22. PubMed ID: 8482191
    [Abstract] [Full Text] [Related]

  • 17. Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy.
    Patil DH, Westaby D, Mahida YR, Palmer KR, Rees R, Clark ML, Dawson AM, Silk DB.
    Gut; 1987 Mar 23; 28(3):255-9. PubMed ID: 3570029
    [Abstract] [Full Text] [Related]

  • 18. [Nonabsorbable disaccharides for the treatment of hepatic encephalopathy--a systemic review of randomized clinical trials--a secondary publication].
    Als-Nielsen BE, Gluud LL, Gluud CN.
    Ugeskr Laeger; 2005 Jan 10; 167(2):179-82. PubMed ID: 15697132
    [No Abstract] [Full Text] [Related]

  • 19. Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis.
    Gluud LL, Vilstrup H, Morgan MY.
    Hepatology; 2016 Sep 10; 64(3):908-22. PubMed ID: 27081787
    [Abstract] [Full Text] [Related]

  • 20. Dopaminergic agonists for hepatic encephalopathy.
    Als-Nielsen B, Gluud LL, Gluud C.
    Cochrane Database Syst Rev; 2004 Oct 18; (4):CD003047. PubMed ID: 15495041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.